• Aucun résultat trouvé

The collaboration of clinical pharmacists and physicians for medication safety

N/A
N/A
Protected

Academic year: 2021

Partager "The collaboration of clinical pharmacists and physicians for medication safety"

Copied!
3
0
0

Texte intégral

(1)

HAL Id: hal-02434540

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02434540

Submitted on 13 Feb 2020

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

The collaboration of clinical pharmacists and physicians for medication safety

Alice Ballerie, Lilian Alix, Emma Bajeux, Patrick Jego, Alain Lescoat, Benoit Hue

To cite this version:

Alice Ballerie, Lilian Alix, Emma Bajeux, Patrick Jego, Alain Lescoat, et al.. The collaboration of clinical pharmacists and physicians for medication safety. Lancet, Elsevier, 2019, 394 (10216), pp.2240.

�10.1016/S0140-6736(19)32608-X�. �hal-02434540�

(2)

19tl4493Corr

The collaboration of clinical pharmacists and physicians for

medication safety

The Comment1 (published July 27, 2019) by Maxwell and Webb on prescribing safety assessment rightfully highlights the central role of education and training to improving the safe delivery of medicines.

In 2017, the WHO’s Global Patient Safety Challenge identified three key action areas (polypharmacy, high-risk situations, and transitions of care) to reduce severe and avoidable medication-related harm.2 To successfully achieve this objective, we believe that the combined work of clinical pharmacists and physicians is essential in each of these areas and should occur at every stage of the patient care pathway, including hospitalisation and transitions of care, as they are both high risk periods for medication mistakes.3 Given the complexity of the prescribing process and considering the frequent workflow interruptions and stress sources for prescribers in daily practice, the implementation of physician learning programmes might be warranted, but not sufficient, to guarantee the safe and effective use of medicines. The combined intervention of clinical pharmacists and physicians within a collaborative medication reconciliation process has a high potential for reducing downstream clinical errors and could be efficient in all WHO action areas described above.2,3

Further, even if studies proved medication reconciliation to be efficient to reduce medication errors, its effect on hard patient outcomes, such as adverse drug events and hospital readmissions, are debated and controversial.3,4 A multicentre,

(3)

prospective study (NCT04018781) associated with qualitative research methods that explore the organisational, clinical, and economic effects of medication reconciliation, especially for older patients after hospital discharge, could help to highlight the strength of this collaboration of clinical pharmacists with physicians for prescribing safety.5

We declare no competing interests. Centre Hospitalier Universitaire de Rennes received a grant from the Ministry of Health through a call for projects that aims to develop clinical pharmacy inside French health-care institutions.

Alice Ballerie, Lilian Alix, Emma Bajeux, Patrick Jégo, Alain Lescoat,

*Benoît Hue

benoit.hue@chu-rennes.fr Unité de Médecine interne polyvalente, Site Pontchaillou (AB, BH), Unité de Médecine post- urgences, site Saint-Laurent (LA), Service d’Epidémiologie et de Santé publique (EB), Unité de Médecine Interne et Immunologie Clinique, Site hôpital sud (PJ), Univ Rennes, Inserm, EHESP, Institut de recherche en santé, environnement et travail (AL), and Service de Pharmacie (BH), Centre Hospitalier Universitaire de Rennes, Rennes 35000, France

1 Maxwell SRJ, Webb DJ. Improving medication safety: focus on prescribers and systems.

Lancet 2019; 394: 283–85.

2 WHO. The third WHO global patient safety challenge: medication without harm. 2017.

https://www.who.int/patientsafety/

medicationsafety/medication-without-harm- brochure/en/ (accessed July 11, 2019).

3 Mekonnen AB, McLachlan AJ, Brien JA.

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open 2016; 6:

e010003.

4 Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev 2016; 2:

CD008986.

Références

Documents relatifs

Given the high proportion of individu- als in Canada who are overweight or obese, and the potential health benefits to patients of losing even 5% to 10% of their body weight,

The rate of malformations in those exposed to acyclovir cream and penciclovir cream in the first trimester (2.3%, 65 of 2850 infants, and 4.2%, 5 of 118 infants,

This illustrates the challenge that health care professionals encounter at transitions of care (see Annex 1), as polypharmacy in combination with an insufficient knowledge of

patient-held medication record (medication passport), information technology systems to facilitate reconciliation processes, and electronic health records to facilitate

- Linear regression: predictive models and to evaluate effects - Statistical modeling in the presence of interaction and confusion - Diagnosis of the linear regression model.

The draft strategic plan for the Global Patient Safety Challenge - Medication Safety (submitted for review prior to the event) was discussed in a group work

It is intended to engage patients in their own care in a more active way, to encourage their curiosity about the medications they are taking, and to empower them to communicate

It is intended to engage patients in their own care in a more active way, to encourage their curiosity about the medications they are taking, and to empower them to communicate